Edition:
United Kingdom

People: Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

16.58CNY
16 Jan 2019
Change (% chg)

¥0.17 (+1.04%)
Prev Close
¥16.41
Open
¥16.47
Day's High
¥16.62
Day's Low
¥16.29
Volume
8,104,912
Avg. Vol
7,340,326
52-wk High
¥27.29
52-wk Low
¥15.79

Shen, Bo 

Mr. Shen Bo has been serving as Chief Financial Officer, Vice President and Executive Director in Shanghai Pharmaceuticals Holding Co., Ltd. since October 2016. He also serves as Non-Executive Director in Tianda Pharmaceuticals Limited and Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. He was Deputy Manager-Finance in Shanghai Jinling Co., Ltd, Chief Financial Officer in Shanghai Industrial Pharmaceutical Investment Co Ltd. and another company, as well as General Manager-Finance in Shanghai Pharmaceutical (Group) Co., Ltd. He holds a Master's degree in Accounting from The Chinese University of Hong Kong, and a Bachelor's degree in Accounting from a university which is now called Tongji University, China. He is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, CNY --
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 2,438,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jun Zhou

--

Min Zuo

3,035,400

Bo Shen

2,438,200

Yongzhong Li

3,030,900

Dawei Liu

1,776,900

Haoliang Gu

2,248,000
As Of  31 Dec 2017